J. Andrew MacKay

8.1k total citations · 3 hit papers
98 papers, 6.6k citations indexed

About

J. Andrew MacKay is a scholar working on Molecular Biology, Genetics and Biomaterials. According to data from OpenAlex, J. Andrew MacKay has authored 98 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 35 papers in Genetics and 21 papers in Biomaterials. Recurrent topics in J. Andrew MacKay's work include Connective tissue disorders research (29 papers), RNA Interference and Gene Delivery (15 papers) and Ocular Surface and Contact Lens (13 papers). J. Andrew MacKay is often cited by papers focused on Connective tissue disorders research (29 papers), RNA Interference and Gene Delivery (15 papers) and Ocular Surface and Contact Lens (13 papers). J. Andrew MacKay collaborates with scholars based in United States, United Kingdom and Netherlands. J. Andrew MacKay's co-authors include Francis C. Szoka, Jean M. J. Fréchet, Cameron Lee, Siti M. Janib, Ara S. Moses, Ashutosh Chilkoti, Jonathan R. McDaniel, Wenge Liu, Sarah F. Hamm‐Alvarez and Mingnan Chen and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

J. Andrew MacKay

96 papers receiving 6.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Designing dendrimers for biological applications

2005 1.7k citations J. Andrew MacKay, Francis C. Szoka et al. profile →
Imaging and drug delivery using theranostic nanoparticles

2010 918 citations Siti M. Janib, Ara S. Moses et al. Advanced Drug Delivery Reviews profile →
Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection

2009 500 citations J. Andrew MacKay, Mingnan Chen et al. Nature Materials profile →

Peers

Countries citing papers authored by J. Andrew MacKay

Since Specialization

Citations

This map shows the geographic impact of J. Andrew MacKay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Andrew MacKay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Andrew MacKay more than expected).

Fields of papers citing papers by J. Andrew MacKay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Andrew MacKay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Andrew MacKay. The network helps show where J. Andrew MacKay may publish in the future.

Co-authorship network of co-authors of J. Andrew MacKay

This figure shows the co-authorship network connecting the top 25 collaborators of J. Andrew MacKay. A scholar is included among the top collaborators of J. Andrew MacKay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Andrew MacKay. J. Andrew MacKay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	FLT3/CD99 Bispecific Antibody–Based Nanoparticles for Acute Myeloid Leukemia 2024 ·Cancer Research Communications ·(unknown), (unknown), (unknown), (unknown), (unknown), Ryan Chu, (unknown), J. Andrew MacKay, Houda Alachkar	1
2	Enhanced T cell activation and cytotoxicity against AML via targeted anti-CD99 nanoparticle treatment 2024 ·Biomedicine & Pharmacotherapy ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), J. Andrew MacKay, Houda Alachkar	1
3	Noncovalent Conjugation of OVA323 to ELP Micelles Increases Immune Response 2024 ·Biomacromolecules ·(unknown), (unknown), Ye Zeng, René C. L. Olsthoorn, Grégory F. Schneider, Bram Slütter, J. Andrew MacKay, Wim Jiskoot, Alexander Kros	0
4	Pharmacokinetic model of human exposure to ciprofloxacin through consumption of fish 2023 ·Environmental Toxicology and Pharmacology ·(unknown), Karen M. K. Chan, (unknown), J. Andrew MacKay, Ian S. Haworth	7
5	Biomimetic SARS-CoV-2 Spike Protein Nanoparticles 2023 ·Biomacromolecules ·(unknown), (unknown), J. Andrew MacKay	6
6	Supra-lacrimal protein-based carriers for cyclosporine A reduce Th17-mediated autoimmunity in murine model of Sjögren's syndrome 2022 ·Biomaterials ·Hao Guo, (unknown), (unknown), Maria C. Edman, Stan G. Louie, Sarah F. Hamm‐Alvarez, J. Andrew MacKay	12
7	Hydra-Elastin-like Polypeptides Increase Rapamycin Potency When Targeting Cell Surface GRP78 2022 ·Biomacromolecules ·(unknown), (unknown), (unknown), (unknown), Anh T. Truong, (unknown), Hao Guo, Shin‐Jae Lee, M. Alba, (unknown), Vicky Yamamoto, James C. Paton, Adrienne W. Paton, Amy S. Lee, J. Andrew MacKay	5
8	Bet v 1-displaying elastin-like polypeptide nanoparticles induce a strong humoral and weak CD4+ T-cell response against Bet v 1 in a murine immunogenicity model 2022 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), Lorenz Aglas, (unknown), (unknown), (unknown), J. Andrew MacKay, (unknown), Grégory F. Schneider, René C. L. Olsthoorn, Wim Jiskoot, Ronald van Ree, Alexander Kros	4
9	Intracellular Dynamin Elastin-like Polypeptides Assemble into Rodlike, Spherical, and Reticular Dynasomes 2021 ·Biomacromolecules ·(unknown), Anh T. Truong, (unknown), Shinjae Park, (unknown), (unknown), Curtis T. Okamoto, Sarah F. Hamm‐Alvarez, J. Andrew MacKay	2
10	Thermally-Responsive Loading and Release of Elastin-Like Polypeptides from Contact Lenses 2019 ·Pharmaceutics ·Wan Wang, (unknown), (unknown), Gordon W. Laurie, J. Andrew MacKay	7
11	The humanin peptide mediates ELP nanoassembly and protects human retinal pigment epithelial cells from oxidative stress 2019 ·Nanomedicine Nanotechnology Biology and Medicine ·Zhe Li, Parameswaran G. Sreekumar, (unknown), David R. Hinton, Ram Kannan, J. Andrew MacKay	19
12	Inhibition of Cathepsin S Reduces Lacrimal Gland Inflammation and Increases Tear Flow in a Mouse Model of Sjögren’s Syndrome 2019 ·Scientific Reports ·Wannita Klinngam, Srikanth Reddy Janga, (unknown), (unknown), (unknown), Mihir Shah, Hao Guo, Dandan Wang, J. Andrew MacKay, Maria C. Edman, Sarah F. Hamm‐Alvarez	35
13	Intra-vitreal αB crystallin fused to elastin-like polypeptide provides neuroprotection in a mouse model of age-related macular degeneration 2018 ·Journal of Controlled Release ·Parameswaran G. Sreekumar, Zhe Li, Wan Wang, Christine Spee, David R. Hinton, Ram Kannan, J. Andrew MacKay	40
14	Tear-mediated delivery of nanoparticles through transcytosis of the lacrimal gland 2014 ·Journal of Controlled Release ·(unknown), Maria C. Edman, (unknown), Pu Shi, Shi Xu, Yi‐An Lin, Honggang Cui, Sarah F. Hamm‐Alvarez, J. Andrew MacKay	16
15	A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sjögren's syndrome 2013 ·Journal of Controlled Release ·Mihir Shah, Maria C. Edman, Srikanth Reddy Janga, Pu Shi, Jugal P. Dhandhukia, Siyu Liu, Stan G. Louie, Kathleen E. Rodgers, J. Andrew MacKay, Sarah F. Hamm‐Alvarez	95
16	NANOSCALE SELF-ASSEMBLY FOR DELIVERY OF THERAPEUTICS AND IMAGING AGENTS 2011 ·Technology & Innovation ·Mingnan Chen, Jonathan R. McDaniel, J. Andrew MacKay, Ashutosh Chilkoti	4
17	Imaging and drug delivery using theranostic nanoparticles breakdown → 2010 ·Advanced Drug Delivery Reviews ·Siti M. Janib, Ara S. Moses, J. Andrew MacKay	918
18	Self-assembling chimeric polypeptide–doxorubicin conjugate nanoparticles that abolish tumours after a single injection breakdown → 2009 ·Nature Materials ·J. Andrew MacKay, Mingnan Chen, Jonathan R. McDaniel, Wenge Liu, Andrew J. Simnick, Ashutosh Chilkoti	500
19	Environmentally responsive peptides as anticancer drug carriers☆ 2009 ·Advanced Drug Delivery Reviews ·Suhaas Aluri, Siti M. Janib, J. Andrew MacKay	98
20	HIV TAT Peptide Modifies the Distribution of DNA Nanolipoparticles Following Convection-enhanced Delivery 2008 ·Molecular Therapy ·J. Andrew MacKay, Weijun Li, Zhaohua Huang, Edward E. Dy, Grace Huynh, Tarık Tihan, Rodney Collins, Dennis F. Deen, Francis C. Szoka	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact